CME Group Inc. $CME Stock Holdings Trimmed by Bessemer Group Inc.

Posted by Nicole Kennedy on May 15th, 2026

Bessemer Group Inc. lowered its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 3.9% during the 4th quarter, Holdings Channel reports. The fund owned 878,171 shares of the financial services provider’s stock after selling 35,688 shares during the period. Bessemer Group Inc.’s holdings in CME Group were worth $239,812,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other hedge funds have also recently added to or reduced their stakes in the business. West Family Investments Inc. raised its stake in CME Group by 1.2% during the 3rd quarter. West Family Investments Inc. now owns 3,062 shares of the financial services provider’s stock valued at $827,000 after acquiring an additional 37 shares in the last quarter. Asset Dedication LLC raised its stake in CME Group by 64.9% during the 4th quarter. Asset Dedication LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 37 shares in the last quarter. Rehmann Capital Advisory Group raised its stake in CME Group by 4.3% during the 3rd quarter. Rehmann Capital Advisory Group now owns 898 shares of the financial services provider’s stock valued at $243,000 after acquiring an additional 37 shares in the last quarter. Atlatl Advisers LLC raised its stake in CME Group by 1.8% during the 3rd quarter. Atlatl Advisers LLC now owns 2,126 shares of the financial services provider’s stock valued at $574,000 after acquiring an additional 38 shares in the last quarter. Finally, 1248 Management LLC raised its stake in CME Group by 26.8% during the 3rd quarter. 1248 Management LLC now owns 180 shares of the financial services provider’s stock valued at $49,000 after acquiring an additional 38 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

CME Group Stock Up 0.2%

CME opened at $297.70 on Friday. CME Group Inc. has a one year low of $257.17 and a one year high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock’s fifty day moving average is $298.49 and its 200-day moving average is $287.99. The company has a market capitalization of $107.87 billion, a PE ratio of 25.40, a P/E/G ratio of 3.59 and a beta of 0.23.

CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings data on Wednesday, April 22nd. The financial services provider reported $3.36 EPS for the quarter, topping analysts’ consensus estimates of $3.11 by $0.25. CME Group had a return on equity of 15.42% and a net margin of 63.19%.The company had revenue of $1.88 billion for the quarter, compared to the consensus estimate of $1.77 billion. During the same quarter in the previous year, the business earned $2.80 EPS. The company’s quarterly revenue was up 14.5% compared to the same quarter last year. On average, equities analysts predict that CME Group Inc. will post 12.26 EPS for the current fiscal year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 25th. Stockholders of record on Tuesday, June 9th will be paid a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.7%. The ex-dividend date of this dividend is Tuesday, June 9th. CME Group’s payout ratio is currently 44.37%.

Wall Street Analyst Weigh In

Several analysts have weighed in on the company. Deutsche Bank Aktiengesellschaft cut their target price on CME Group from $342.00 to $322.00 and set a “buy” rating on the stock in a research note on Thursday, April 23rd. The Goldman Sachs Group cut their target price on CME Group from $275.00 to $267.00 and set a “sell” rating on the stock in a research note on Thursday, April 23rd. Weiss Ratings raised CME Group from a “buy (b+)” rating to a “buy (a-)” rating in a research note on Monday, March 2nd. UBS Group reaffirmed a “neutral” rating and set a $310.00 target price on shares of CME Group in a research note on Friday, February 6th. Finally, Raymond James Financial lifted their target price on CME Group from $310.00 to $320.00 and gave the company an “outperform” rating in a research note on Monday, April 6th. Two analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Moderate Buy” and an average price target of $305.29.

Read Our Latest Research Report on CME

Key Stories Impacting CME Group

Here are the key news stories impacting CME Group this week:

Positive Sentiment: CME Group announced plans to launch Nasdaq CME Crypto Index futures on June 8, expanding its regulated crypto offerings and potentially driving additional trading activity. CME Group to Launch Nasdaq CME Crypto Index Futures
Positive Sentiment: The new futures product is CME’s first market-cap weighted contract, which could broaden participation from both institutional and active retail traders. CME Group to Launch Nasdaq CME Crypto Index Futures
Positive Sentiment: Interactive Brokers also said it will integrate CME Group event contracts into a unified prediction-market platform, which may improve distribution and accessibility for CME-linked products. Interactive Brokers Rolls Out Centralized Prediction Market Trading Hub with Kalshi Partnership
Neutral Sentiment: CME Group also released preliminary annual meeting results, including board elections, but the update appears routine and is unlikely to materially affect the stock. CME Group Inc. Announces Preliminary Results of 2026 Annual Meeting
Neutral Sentiment: Recent analyst commentary remains moderately constructive, but does not appear to be the main driver of the move. Do Wall Street Analysts Like CME Group Stock?

Insider Transactions at CME Group

In related news, Director Bryan T. Durkin sold 4,200 shares of CME Group stock in a transaction on Monday, February 23rd. The stock was sold at an average price of $309.65, for a total value of $1,300,530.00. Following the transaction, the director directly owned 43,007 shares in the company, valued at $13,317,117.55. The trade was a 8.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, General Counsel Jonathan L. Marcus sold 3,291 shares of CME Group stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $333.37, for a total value of $1,097,120.67. Following the completion of the transaction, the general counsel owned 7,192 shares in the company, valued at $2,397,597.04. The trade was a 31.39% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 7,791 shares of company stock valued at $2,489,421. Corporate insiders own 0.30% of the company’s stock.

About CME Group

(Free Report)

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.